.AstraZeneca has discussed a very early look at the efficiency of its own internal antibody-drug con...
.After revealing a period 3 launch based upon positive midstage results, iTeos and also GSK are actu...
.The FDA ought to be a lot more available and also collaborative to discharge a surge in approvals o...
.It's an extraordinarily active Friday for biotech IPOs, with Zenas BioPharma, MBX as well as Bicara...
.Atea Pharmaceuticals' antiviral has fallen short one more COVID-19 test, yet the biotech still stor...
.Neurocrine Biosciences' schizophrenia program pivot has failed. The biotech was not able to reprodu...
.Sanofi has actually created a late entrance to the radioligand event, spending 100 million euros ($...
.After F2G's first attempt to obtain a brand-new course of antifungal to market was derailed by the ...
.Moderna has sworn to reduce R&D investing by $1.1 billion through 2027. The choice to retract th...
.Merely four months after Sanofi bet $80 million in beforehand cash on Fulcrum Rehabs' losmapimod, t...